Ken Griffin THERAVANCE BIOPHARMA INC Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	N/A	-45,128,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	N/A	-12,000,000 Reduced 21.01%	45,128,000 $0
Q1 2021 May 17, 2021	SELL	N/A	-3,000,000 Reduced 4.99%	57,128,000 $58.4 Million
Q3 2020 Nov 16, 2020	SELL	N/A	-14,000,000 Reduced 18.89%	60,128,000 $53.4 Million
Q2 2020 Aug 14, 2020	BUY	N/A	10,250,000 Added 16.05%	74,128,000 $72.1 Million
Q1 2020 May 15, 2020	BUY	N/A	3,940,000 Added 6.57%	63,878,000 $63.3 Million
Q4 2019 Feb 14, 2020	BUY	N/A	5,000,000 Added 9.1%	59,938,000 $62.9 Million
Q3 2019 Nov 14, 2019	BUY	N/A	1,500,000 Added 2.81%	54,938,000 $0
Q2 2019 Aug 14, 2019	BUY	N/A	24,000,000 Added 81.53%	53,438,000 $46.4 Million
Q1 2019 May 15, 2019	BUY	N/A	2,000,000 Added 7.29%	29,438,000 $0
Q4 2018 Feb 14, 2019	BUY	N/A	1,528,000 Added 5.9%	27,438,000 $0
Q2 2018 Aug 10, 2018	BUY	N/A	5,000,000 Added 23.91%	25,910,000 $0
Q1 2018 May 11, 2018	SELL	N/A	-5,000,000 Reduced 19.3%	20,910,000 $21.3 Million
Q4 2017 Feb 09, 2018	SELL	N/A	-6,000,000 Reduced 18.8%	25,910,000 $28.4 Million
Q3 2017 Nov 09, 2017	BUY	N/A	31,910,000	31,910,000 $39.2 Million

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.